Assessing the causality between pulmonary arterial hypertension and cancer: insights from Mendelian randomization
This study highlights that PAH may serve as a potential risk factor for this liver cancer. Future research should aim to elucidate the biological mechanisms at play and explore the potential for early interventions that could mitigate cancer risk in this vulnerable population.
Authors
- Xinwang Duan (ORCID: https://orcid.org/0000-0002-0432-3638)
- Wei Zhou (ORCID: https://orcid.org/0009-0002-1507-3600)
- Yang Fu (ORCID: https://orcid.org/0000-0003-3770-5074)
Institutions
- Nanchang University (CN)
- Second Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-12-21
- DOI
- https://doi.org/10.1007/s12672-024-01727-1
- Citations
- 1
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.42